(Q68770177)

English

The effect of a new adrenergic beta 2 -receptor-stimulating agent (rimiterol, R798) in patients with chronic obstructive lung disease

scientific article published on 01 January 1972

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

4404808

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4404808%20AND%20SRC:MED&resulttype=core&format=json

retrieved

27 September 2019

title

The effect of a new adrenergic beta 2 -receptor-stimulating agent (rimiterol, R798) in patients with chronic obstructive lung disease (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

4404808

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4404808%20AND%20SRC:MED&resulttype=core&format=json

retrieved

27 September 2019

main subject

chronic obstructive pulmonary disease

1 reference

Svedmyr N

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

4404808

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4404808%20AND%20SRC:MED&resulttype=core&format=json

retrieved

27 September 2019

Malmberg R

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

4404808

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4404808%20AND%20SRC:MED&resulttype=core&format=json

retrieved

27 September 2019

Thiringer G

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

4404808

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4404808%20AND%20SRC:MED&resulttype=core&format=json

retrieved

27 September 2019

publication date

1 January 1972

1 reference

stated in

Europe PubMed Central

PubMed publication ID

4404808

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4404808%20AND%20SRC:MED&resulttype=core&format=json

retrieved

27 September 2019

published in

Scandinavian journal of respiratory diseases

1 reference

stated in

Europe PubMed Central

PubMed publication ID

4404808

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4404808%20AND%20SRC:MED&resulttype=core&format=json

retrieved

27 September 2019

volume

53

1 reference

stated in

Europe PubMed Central

PubMed publication ID

4404808

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4404808%20AND%20SRC:MED&resulttype=core&format=json

retrieved

27 September 2019

issue

5

1 reference

stated in

Europe PubMed Central

PubMed publication ID

4404808

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4404808%20AND%20SRC:MED&resulttype=core&format=json

retrieved

27 September 2019

page(s)

302-313

1 reference

stated in

Europe PubMed Central

PubMed publication ID

4404808

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4404808%20AND%20SRC:MED&resulttype=core&format=json

retrieved

27 September 2019

Identifiers

PubMed publication ID

4404808

1 reference

stated in

Europe PubMed Central

PubMed publication ID

4404808

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4404808%20AND%20SRC:MED&resulttype=core&format=json

(Q68770177)

The effect of a new adrenergic beta 2 -receptor-stimulating agent (rimiterol, R798) in patients with chronic obstructive lung disease

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)